Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions

Paul A. Greenberger

doi:10.1016/j.jaip.2020.04.002

Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions

Paul A. Greenberger^*

^*Corresponding author for this work

Medicine, Allergy Division

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1906-1907
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	8
Issue number	6
DOIs	https://doi.org/10.1016/j.jaip.2020.04.002
State	Published - Jun 2020

Funding

This work was supported by the Ernest S. Bazley Foundation grants to Northwestern Memorial Hospital and Northwestern University. Conflicts of interest: The author declares that he has no relevant conflicts of interest. He does receive royalties from Wolters Kluwer for Up To Date reviews and a book royalty, research funding from the NIAID to Northwestern University, and medical legal fees for consulting.

ASJC Scopus subject areas

Immunology and Allergy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaip.2020.04.002

Cite this

@article{4322fa2d6ad24c7aa013d756ad691bf6,

title = "Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions",

author = "Greenberger, \{Paul A.\}",

note = "Funding Information: This work was supported by the Ernest S. Bazley Foundation grants to Northwestern Memorial Hospital and Northwestern University. Funding Information: Conflicts of interest: The author declares that he has no relevant conflicts of interest. He does receive royalties from Wolters Kluwer for Up To Date reviews and a book royalty, research funding from the NIAID to Northwestern University, and medical legal fees for consulting. ",

year = "2020",

month = jun,

doi = "10.1016/j.jaip.2020.04.002",

language = "English (US)",

volume = "8",

pages = "1906--1907",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "6",

}

TY - JOUR

T1 - Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions

AU - Greenberger, Paul A.

N1 - Funding Information: This work was supported by the Ernest S. Bazley Foundation grants to Northwestern Memorial Hospital and Northwestern University. Funding Information: Conflicts of interest: The author declares that he has no relevant conflicts of interest. He does receive royalties from Wolters Kluwer for Up To Date reviews and a book royalty, research funding from the NIAID to Northwestern University, and medical legal fees for consulting.

PY - 2020/6

Y1 - 2020/6

UR - http://www.scopus.com/inward/record.url?scp=85085658343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085658343&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2020.04.002

DO - 10.1016/j.jaip.2020.04.002

M3 - Editorial

C2 - 32499036

AN - SCOPUS:85085658343

SN - 2213-2198

VL - 8

SP - 1906

EP - 1907

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 6

ER -

Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this